Assyro AI

Orange Book product · Brand (NDA)

OLPRUVA

SODIUM PHENYLBUTYRATE

Brand (NDA)NDA 214860RX ACER

At a glance

Dec 22, 2022

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 22, 2022

    3 yr 7 mo ago

  2. Today

  3. Patent 11154521 expires

    Listed drug product patent expiration.

    Oct 17, 2036

    in 10 yr 6 mo

  4. Patent 11202767 expires

    Listed method-of-use patent (U-3502) expiration.

    Oct 17, 2036

    in 10 yr 6 mo

  5. Patent 11433041 expires

    Listed drug product patent expiration.

    Oct 17, 2036

    in 10 yr 6 mo

Pharmaceutical detail

Active ingredient

SODIUM PHENYLBUTYRATE

Strength

2GM/PACKET

Dosage form

FOR SUSPENSION

Route

ORAL

TE code

Not listed

Application

NDA 214860

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11154521Oct 17, 2036in 10 yr 6 mo
Product
11202767Oct 17, 2036in 10 yr 6 mo
U-3502
11433041Oct 17, 2036in 10 yr 6 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.